No need yet to adapt Pfizer vaccine for Covid variants: BioNTech chief

The first generation vaccine developed by BioNTech-Pfizer works against coronavirus variants such as the Delta strain and does not need to be modified for the moment, the chief executive of German company BioNTech said Monday.